Publication & Citation Trends
Publications
0 total
Highly selective tyrosine kinase 2 inhibition with zasocitinib (TAK-279) improves outcomes in patients with active psoriatic arthritis: a randomised phase 2b study.
Cited by 6
Semantic Scholar
Efficacy and safety of izokibep in patients with active psoriatic arthritis: a randomised, double-blind, placebo-controlled, phase 2 study.
Cited by 7
Semantic Scholar
Efficacy and Safety of Intravenous Secukinumab in Patients With Active Axial Spondyloarthritis: Results From a Randomized, Placebo‐Controlled, Phase 3 Study
Cited by 4
Semantic Scholar
Proposed Denosumab Biosimilar SB16 vs Reference Denosumab in Postmenopausal Osteoporosis: Phase 3 Results Up to Month 12 OA
Cited by 9
Semantic Scholar
Equivalence trial of proposed denosumab biosimilar GP2411 and reference denosumab in postmenopausal osteoporosis: the ROSALIA study OA
Cited by 14
Semantic Scholar
Effect of treatment with original or biosimilar adalimumab on SARS-CoV2 vaccination antibody titers OA
Cited by 2
Semantic Scholar
USE OF MIDAZOLAM IN PAEDIATRIC DENTISTRY OA
Cited by 0
Semantic Scholar
Usability Study of PF-06410293, an Adalimumab Biosimilar, by Prefilled Pen: Open-Label, Single-Arm, Sub-Study of a Phase 3 Trial in Patients with Rheumatoid Arthritis OA
Cited by 5
Semantic Scholar
Research Topics
Rheumatoid Arthritis Research and Therapies
(33)
Autoimmune and Inflammatory Disorders Research
(23)
Spondyloarthritis Studies and Treatments
(19)
Biosimilars and Bioanalytical Methods
(18)
Psoriasis: Treatment and Pathogenesis
(16)
Affiliations
University of Veterinary Sciences Brno
Novartis (Switzerland)
Masaryk University
Leiden University Medical Center
Medical Plus